FDA updates its database about all licensed biological products

 

The FDA has recently updated the “Purple Book” — a database containing information about all licensed biological products — new additions include patent information relating to biologics as well as FDA regulatory exclusivity information.

 

According to Pharmaceutical Online, the directory provides the opportunity for:

(i) potential partnerships for licensing of existing intellectual property;

(ii) new strategies regarding intellectual property enforcement and protection; and, potentially,

(iii) opportunities for the development of new technology.


Here is the link: https://purplebooksearch.fda.gov/ 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)